Coexistent sarcoidosis mimics metastasis in a patient with early-stage non-small cell lung cancer: a case report
Coexistent Sarcoidosis and NSCLC
Keywords:
Sarcoidosis, NSCLC, Metastasis;Abstract
Background and aim: Sarcoidosis is a granulomatous disease. Malignant tumors are accompanied rarely by granuloma reactions that mimic metastasis. Methods: We present the case of a patient with possible advanced lung cancer with metastases to the mediastinal lymph nodes and bilateral ilia. Results: Ilium biopsy revealed the presence of sarcoid-like reaction. Bronchoscopy and endobronchial ultrasound revealed an adenocarcinoma in the right upper lung lobe, with a negative mediastinal lymph node. The correct staging of lung cancer was achieved through pathological examination of the surgically removed lung tissues. Two years later, the lung cancer metastasized, and the patient underwent systemic treatment. Conclusions: Coexistent sarcoid-like reaction may mimic metastatic lung cancer. A multidisciplinary approach and sequential diagnostic biopsies can prevent unnecessary surgery or inadequate treatment by distinguishing between coexistent sarcoidosis and metastatic lung cancer.
References
Zhou Y, Lower EE, Li H, Farhey Y, Baughman RP. Clinical characteristics of patients with bone sarcoidosis. Semin Arthritis Rheum 2017; 47: 143-8. doi:10.1016/j.semarthrit.2017.02.004
Moore S, Kransdorf MJ, Schweitzer ME, Murphey MD, Babb JS. Can Sarcoidosis and Metastatic Bone Lesions Be Reliably Differentiated on Routine MRI? Am J Roentgenol 2012; 198: 1387-93. doi:10.2214/AJR.11.7498
Herron M, Chong SG, Gleeson L, Nicholson S, Fahy RJ. Paraneoplastic sarcoidosis: a review. QJM 2019; 113: 17-9. doi:10.1093/qjmed/hcz207
Mukhopadhyay S, Wilcox BE, Myers JL, et al. Pulmonary Necrotizing Granulomas of Unknown Cause Clinical and Pathologic Analysis of 131 Patients With Completely Resected Nodules. Chest 2013; 144: 813-24. doi:10.1378/chest.12-2113
Albert D: Does Cancer Masquerade as Sarcoidosis? J Clin Rheumatol 2022; 28: 416-9. doi:10.1097/RHU.0000000000001900
Ji J, Shu X, Li X, Sundquist K, Sundquist J, Hemminki K. Cancer risk in hospitalized sarcoidosis patients: a follow-up study in Sweden. Ann Oncol 2009; 20: 1121-6. doi:10.1093/annonc/mdn767
Le Jeune I, Gribbin J, West J, Smith C, Cullinan P, Hubbard R. The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. Respir Med 2007; 101: 2534-40. doi:10.1016/j.rmed.2007.07.012
Kamiyoshihara M, Hirai T, Kawashima O, Ishikawa S, Morishita Y. Sarcoid reactions in primary pulmonary carcinoma: report of seven cases. Oncol Rep 1998; 5: 177-257. doi:10.3892/or.5.1.177
Tomimaru Y, Higashiyama M, Okami J, et al. Surgical results of lung cancer with sarcoid reaction in regional lymph nodes. Jpn J Clin Oncol 2007; 37: 90-5. doi:10.1093/jjco/hyl141
Yamasawa H, Ishii Y, Kitamura S. Concurrence of sarcoidosis and lung cancer. A report of four cases. Respiration 2000; 67: 90-3. doi:10.1159/000029470
Kachalia AG, Ochieng P, Kachalia K, Rahman H. Rare coexistence of sarcoidosis and lung adenocarcinoma. Respir Med Case Rep 2014; 12: 4-6. doi:10.1016/j.rmcr.2013.12.008
Sakthivel P, Bruder D. Mechanism of granuloma formation in sarcoidosis. Curr Opin Hematol 2017; 24: 59-65. doi:10.1097/MOH.0000000000000301
Braun NA, Celada LJ, Herazo-Maya JD, et al. Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity. Am J Respir Crit Care Med 2014; 190: 560-71. doi:10.1164/rccm.201401-0188OC
Oswald-Richter KA, Richmond BW, Braun NA, et al. Reversal of global CD4+ subset dysfunction is associated with spontaneous clinical resolution of pulmonary sarcoidosis. J Immunol 2013; 190: 5446-53. doi:10.4049/jimmunol.1202891
Broos CE, Hendriks RW, Kool M. T-cell immunology in sarcoidosis: Disruption of a delicate balance between helper and regulatory T-cells. Curr Opin Pulm Med 2016; 22: 476-83. doi:10.1097/MCP.0000000000000303
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Xiang Zhao, Yuan Cheng, Wei Wang
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
